secwatch.observer — SEC 8-K summary
======================================

Issuer:     Karyopharm Therapeutics Inc. (KPTI)
CIK:        0001503802
Form:       8-K
Filed at:   2024-09-17T23:59:59+00:00
Accession:  0001193125-24-220534
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Karyopharm receives Nasdaq deficiency notice for bid price below $1.00
----------------------------------------------------------------------

- Stock closed below $1.00 for 32 consecutive business days, violating Bid Price Rule 5450(a)(1).
- Company has 180 days, until March 17, 2025, to regain compliance by closing at $1.00+ for 10 consecutive days.
- Failure to cure may allow a 180-day extension if stock moves to Nasdaq Capital Market and meets other listing standards.
- Company may consider a reverse stock split, but there is no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1503802/000119312524220534/0001193125-24-220534-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1503802/000119312524220534/d260865d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-220534

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer